Supreme Court to Hear Novartis AG (NVS) Patent Case From Sept 11  
8/22/2012 7:24:37 AM

The Supreme Court will hear final arguments from September 11 in a key patent dispute between Swiss drugmaker Novartis and India's patent office, a case that could curb India's global position as a supplier of cut-price generic medicines. The hearing, which is expected to last for at least two months, had been scheduled to being on Wednesday. Novartis appealed to the Supreme Court after its cancer medicine Glivec was refused a patent on the grounds the drug is not a new molecule but an amended version of a known compound. Novartis has challenged this clause of Indian Patents Act.